Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0191120210360480336
Journal of Korean Medical Science
2021 Volume.36 No. 48 p.336 ~ p.336
Clinical Course of COVID-19 in Patients with Inflammatory Bowel Disease in Korea: a KASID Multicenter Study
Lee Jin-Wook

Song Eun-Mi
Jung Sung-Ae
Jung Sung-Hoon
Kim Kwang-Woo
Koh Seong-Joon
Lee Hyun-Jung
Hong Seung-Wook
Park Jin-Hwa
Hwang Sung-Wook
Yang Dong-Hoon
Ye Byong-Duk
Byeon Jeong-Sik
Myung Seung-Jae
Yang Suk-Kyun
Park Sang-Hyoung
Abstract
In 2020, the novel coronavirus disease 2019 (COVID-19) began to spread worldwide and remains an ongoing medical challenge. This case series reports on the clinical features and characteristics of patients with inflammatory bowel disease (IBD) and confirmed COVID-19 infection. From February 2020 to March 2021, nine patients with IBD had confirmed COVID-19 across four hospitals in Korea. The median age at COVID-19 diagnosis was 42 years. Six patients were male, and seven patients had ulcerative colitis (UC). No patients required oxygen therapy, intensive care unit hospitalizations, or died. The most common symptom was fever, and gastrointestinal (GI) symptoms developed as diarrhea in five patients with UC. Oral steroids were used to combat UC aggravation in two patients. In this case series of nine IBD patients diagnosed with COVID-19 in Korea, the clinical presentation was predominately a mild respiratory tract infection. Most patients with UC developed new GI symptoms including diarrhea.
KEYWORD
COVID-19, Crohn's Disease, Inflammatory Bowel Disease, Ulcerative Colitis
FullTexts / Linksout information
 
Listed journal information
SCI(E) MEDLINE ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø